April 28, 2011 - BioPatterns s.r.o., as a participant, has negotiated about the funding of its research by the Seventh Framework Programme of the European Commission, call Research for the benefit of SMEs (FP7 SME.2011.1).
September 1, 2009 - BioPatterns s.r.o., as a co-participant, has received a grant from the Ministry of Education, Youth and Sports of the Czech Republic under
the "European Social Fund, Education for Competitiveness Operational Programme Period 2007–2013 (ECOP)".
Reg. No. 1.07/2.3.09/09.0035; Project Acronym: EuroExpres – international and innovative education of students and research
workers in pharmacy and biotechnology.
July 1, 2009 - BioPatterns s.r.o. has signed a cooperative research and joint commercialization agreement with the Palacký
University in Olomouc. The coperation will focus on the development of new heterocyclic compounds and their commercialization
as drugs for human diseases.
March 11, 2009 - BioPatterns s.r.o. has received a grant from the Ministry of Industry and Trade of the Czech Republic under the
"Operational Programme Enterprise and Innovations (OPEI) 2007-2013", specifically the "Programme of support INNOVATION – Patent".
BioPatterns expects to receive substantial refunds for its patent filing, translation and maintenance costs.
Reg. No. CZ.1.03/4.1.00/21.00200
February 10, 2009 - BioPatterns s.r.o. has become a founding member of MedChemBio Cluster, active the area of biologically active substances, i.e. substances
that may find application in human and veterinary medicine as drugs. More about the cluster at http://www.medchembio.org/.
December 10, 2008 - BioPatterns s.r.o. has received a grant from the Ministry of Industry and Trade of the Czech Republic under the
"Operational Programme Enterprise and Innovations (OPEI) 2007-2013", specifically the "Programme of support INNOVATION – Patent". The programme is focused
particularly on the support for the commercialisation of R&D results and the transfer of technologies onto markets through innovation activities.
BioPatterns expects to receive substantial refunds under the grant for its patent filing, translation and maintenance costs.
Reg. No. CZ.1.03/4.1.00/21.00153